Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date

Loading news article.

Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date | WAPE

Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date

Article summary

Related companies

Comments —